Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

15.29
-0.1300-0.84%
Post-market: 15.26-0.0300-0.20%16:44 EDT
Volume:979.91K
Turnover:15.05M
Market Cap:1.61B
PE:-9.87
High:15.68
Open:15.06
Low:15.06
Close:15.42
Loading ...

Edgewise Therapeutics Price Target Maintained With a $48.00/Share by RBC Capital

Dow Jones
·
05 Jun

Edgewise Therapeutics to Present at Annual Goldman Sachs Global Healthcare Conference

Reuters
·
03 Jun

Treehouse Foods, GeneDx Holdings See Activist Action -- Barrons.com

Dow Jones
·
17 May

Edgewise Therapeutics Inc. to Present at RBC Capital Markets Global Healthcare Conference

Reuters
·
14 May

Wedbush Adjusts Price Target on Edgewise Therapeutics to $40 From $43, Maintains Outperform Rating

MT Newswires Live
·
09 May

Edgewise Therapeutics' Q1 Net Loss Widens; Shares Down Over 3%

MT Newswires Live
·
08 May

Edgewise Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Edgewise Therapeutics reports Q1 EPS (43c), consensus (42c)

TIPRANKS
·
08 May

BRIEF-Edgewise Therapeutics Q1 Operating Expenses USD 45.959 Million

Reuters
·
08 May

Edgewise Therapeutics Q1 Net Income USD -40.798 Million

THOMSON REUTERS
·
08 May

Edgewise Therapeutics Q1 Operating Expenses USD 45.959 Million

THOMSON REUTERS
·
08 May

Edgewise Therapeutics Inc. Chief Scientific Officer Russell Alan J Reports Disposal of Common Shares

Reuters
·
08 May

John R. Moore, General Counsel, Reports Disposal of Edgewise Therapeutics Inc. Common Shares

Reuters
·
08 May

Why Edgewise Therapeutics Stock Popped This Week

Motley Fool
·
03 May

Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target

MT Newswires Live
·
30 Apr

Guggenheim starts Edgewise with Buy on ‘compelling entry point’

TIPRANKS
·
30 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
06 Apr

Major Stake Acquisitions Signal Confidence in Edgewise Therapeutics

TIPRANKS
·
05 Apr

Edgewise Therapeutics Downgraded Following Safety Issues in Heart Drug Trial

GuruFocus.com
·
04 Apr